Margherita Cortini

Dr. Margherita Cortini

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Cancer Letters
Verified
Journal Article
Closed access
Margherita CortiniMargherita Cortini
Margherita Cortini
Sofia AvnetSofia Avnet
Sofia Avnet
Nicola BaldiniNicola Baldini
Nicola Baldini

6 September 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TATiziana Anelli
Tiziana Anelli
SCStefania Ceppi
Stefania Ceppi
LBLeda Bergamelli
Leda Bergamelli
Margherita CortiniMargherita Cortini
Margherita Cortini
SMSilvia Masciarelli
Silvia Masciarelli
RSRoberto Sitia
Roberto Sitia
The biogenesis of secretory IgM occurs stepwise under stringent quality control, formation of μ2L2 preceding polymerization. How is efficiency of IgM secretion coupled to fidelity? We show here that ERp44, a soluble protein involved in thiol‐mediated retention, interacts with ERGIC‐53. Binding to this hexameric lectin contributes to ERp44 localization in the ER‐golgi intermediate compartment. ERp44 and ERGIC‐53 increase during B‐lymphocyte differentiation, concomitantly with the onset of IgM polymerization. Both preferentially bind μ2L2 and higher order intermediates. Their overexpression or silencing in non‐lymphoid cells promotes or decreases secretion of IgM polymers, respectively. In IgM‐secreting B‐lymphoma cells, μ chains interact first with BiP and later with ERp44 and ERGIC‐53. Our findings suggest that ERGIC‐53 provides a platform that receives μ2L2 subunits from the BiP‐dependent checkpoint, assisting polymerization. In this process, ERp44 couples thiol‐dependent assembly and quality control.

1 October 2016 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
FSFrancesca Vittoria Sbrana
Francesca Vittoria Sbrana
Margherita CortiniMargherita Cortini
Margherita Cortini
Sofia AvnetSofia Avnet
Sofia Avnet
FPFrancesca Perut
Francesca Perut
MCMarta Columbaro
Marta Columbaro
Nicola BaldiniNicola Baldini
Nicola Baldini

16 November 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Margherita CortiniMargherita Cortini
Margherita Cortini
AMAnnamaria Massa
Annamaria Massa
Sofia AvnetSofia Avnet
Sofia Avnet
GBGloria Bonuccelli
Gloria Bonuccelli
Nicola BaldiniNicola Baldini
Nicola Baldini
Osteosarcoma (OS) is an aggressive bone malignancy with a high relapse rate despite combined treatment with surgery and multiagent chemotherapy. As for other cancers, OS-associated microenvironment may contribute to tumor initiation, growth, and metastasis. We consider mesenchymal stromal cells (MSC) as a relevant cellular component of OS microenvironment, and have previously found that the interaction between MSC and tumor cells is bidirectional: tumor cells can modulate their peripheral environment that in turn becomes more favorable to tumor growth through metabolic reprogramming. Here, we determined the effects of MSC on OS stemness and migration, two major features associated with recurrence and chemoresistance. The presence of stromal cells enhanced the number of floating spheres enriched in cancer stem cells (CSC) of the OS cell population. Furthermore, the co-culturing with MSC stimulated the migratory capacity of OS via TGFβ1 and IL-6 secretion, and the neutralizing antibody anti-IL-6 impaired this effect. Thus, stromal cells in combination with OS spheres exploit a vicious cycle where the presence of CSC stimulates mesenchymal cytokine secretion, which in turn increases stemness, proliferation, migration, and metastatic potential of CSC, also through the increase of expression of adhesion molecules like ICAM-1. Altogether, our data corroborate the concept that a comprehensive knowledge of the interplay between tumor and stroma that also includes the stem-like fraction of tumor cells is needed to develop novel and effective anti-cancer therapies.

22 August 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
Sofia AvnetSofia Avnet
Sofia Avnet
SLSilvia Lemma
Silvia Lemma
Margherita CortiniMargherita Cortini
Margherita Cortini
PPPaola Pellegrini
Paola Pellegrini
FPFrancesca Perut
Francesca Perut
Nicola BaldiniNicola Baldini
Nicola Baldini
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance

1 June 2013 in Molecular Cell
Verified
Journal Article
Open access
SVStefano Vavassori
Stefano Vavassori
Margherita CortiniMargherita Cortini
Margherita Cortini
SMShoji Masui
Shoji Masui
SSSara Sannino
Sara Sannino
TATiziana Anelli
Tiziana Anelli
RSRoberto Sitia
Roberto Sitia
To warrant the quality of the secretory proteome, stringent control systems operate at the endoplasmic reticulum (ER)-Golgi interface, preventing the release of nonnative products. Incompletely assembled oligomeric proteins that are deemed correctly folded must rely on additional quality control mechanisms dedicated to proper assembly. Here we unveil how ERp44 cycles between cisGolgi and ER in a pH-regulated manner, patrolling assembly of disulfide-linked oligomers such as IgM and adiponectin. At neutral, ER-equivalent pH, the ERp44 carboxy-terminal tail occludes the substrate-binding site. At the lower pH of the cisGolgi, conformational rearrangements of this peptide, likely involving protonation of ERp44's active cysteine, simultaneously unmask the substrate binding site and -RDEL motif, allowing capture of orphan secretory protein subunits and ER retrieval via KDEL receptors. The ERp44 assembly control cycle couples secretion fidelity and efficiency downstream of the calnexin/calreticulin and BiP-dependent quality control cycles.